Non-Invasive Aesthetic Treatment Market Revenue Will Grow 5.3X From 2022 To 2032, Reaching Nearly US$ 281.2 Bn In 2032.
06 Jul 2022
Collagen Non-Invasive Aesthetic Treatment Market In North America Is Expected To Grow With A CAGR Of 17.8% For The Forecast Period.
In Non-Invasive Aesthetic Treatment Market Kybella, an injectable is gaining the attention as Kybella is a fat-dissolving injection that works on a targeted treatment region. It is a synthetic variant of deoxycholic acid that can damage fat cell membranes. In 2015, the FDA approved the therapy for treating under-chin fat, comments a Fact.MR analyst.
Fact.MR, a market research and competitive intelligence provider: The market size of non-invasive aesthetic treatments was around US$ 53.3 Bn in 2021, and it is expected to grow with the compound annual growth rate (CAGR) of 16.5% for the period of 2022 to 2032.
Injectables are expected to be the highest revenue-generating segment, accounting for an absolute dollar opportunity of nearly US$ 149.7 Bn during 2022 – 2032. The growing focus on physical appearance among adults has led to an increased demand for non-invasive aesthetic treatments in recent years.
The increasing focus on the physical appearances among the young population is the most prominent driver of the global non-invasive aesthetic treatment market. Moreover, the women population aged 50 years and above are increasingly opting for injectables like Botox shots and fillers to enhance their appearance and conceal skin aging. Therefore, the rising aging population across the globe coupled with rising disposable income and growing awareness regarding the aesthetic treatments is fueling the demand for the non-invasive aesthetic treatment.
For more insights into the Market, Get A Sample of this Report!
Key Drivers and Restraints of Global Non-invasive Aesthetic Treatment Market
Increase in geriatric population, rise in adoption of non-invasive aesthetic treatment, and surge in beauty consciousness among consumers are the major drivers of the global non-invasive aesthetic treatment market
According to the American Society of Plastic Surgeons, the number of invasive cosmetic procedures dropped 6% from 2000 to 2016 in the U.S., while non-invasive and minimally invasive procedures witnessed 180% increase during that same period
Availability of technologically advanced & user-friendly products and increase in demand for aesthetic treatments among men are the key factors fueling the growth of the global non-invasive aesthetic treatment market
Moreover, increase in the number of approved products and high efficiency & safety offered by some products boost the growth of the global non-invasive aesthetic treatment market
As per the Non-Invasive Aesthetic Treatment Market industry research by Fact.MR - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Non-Invasive Aesthetic Treatment Market increased at around 14.4% CAGR.
According to the report of American Society of Plastic Surgeons report, the use of Botox injections increased by approximately 84.5% in the United States during the 18 years from 2000 to 2018. With more than 40%, North America held the largest share of global sales in 2021. The region will continue to maintain its leading position as demand for cosmetic surgery increases throughout the forecast period.
For Comprehensive Insights Ask An Analyst Here
The revenue from other segments is also expected to grow at a significant rate,
Collagen non-invasive aesthetic treatment market in North America is expected to grow with a CAGR of 17.8% for the forecast period.
In 2021 the cellulite market had a market share of less than 1% but projected to grow with a CAGR of 18.1% during 2022-2032.
The market for other procedures like hair removal is also projected to grow 5.1X from 2022 to 2032
Key Takeaways from the Market Study
Global Non-Invasive aesthetic market is expected to reach a market size of US$ 61.4 Bn by 2022.
In 2022, North America to contribute more than 40% of market revenue.
Injectables are expected to account for 63.3% of the market revenue in 2022
Skin rejuvenation is estimated to be over US$ 15.55 Bn in 2022, growing a CAGR of over 15.5% for the forecast period.
North America is expected to experience a CAGR of 16.1% across the 2022-2032 forecast period
Competitive Landscape
Companies operational in Non-Invasive Treatment Market compete on the basis of innovation of their products, quality, brand reputation, and market presence to sell their products through various industries. Companies are employing a variety of strategies to remain competitive.
In 2020, Alma introduced a new platform which was hybrid and focused on investigation of several options like ablative, non-ablative, and the thermal therapies on skin rejuvenation and scar revision, also the synergistic effects. Due to this, the availability of user-friendly and technologically improved non-invasive aesthetic solutions is increasing, hence fueling the market
In 2021, Candela launched the Fax Pro system, which was a non-ablative functional device. It was also approved by FDA and marked by CE. The system was the first one that offered dual depth skin resurfacing. With the help of two applicators, it could perform dual depth skin resurfacing, promoting new collagen showing smoother and brighter skin.
In 2021, Lumenis, sold their surgical division to Boston scientific corporation. The reason was they wanted to invest that amount to increase the growth of aesthetic and vision businesses by focusing on R&D, worldwide sales and developing marketing channels.
Market Segments Covered in Non-Invasive Aesthetic Treatment Market Analysis
By Procedure :
Injectables
Botulinum Toxin
Calcium Hydroxylapatite
Hyaluronic Acid
Polymer Filler
Collagen
Skin Rejuvenation
Chemical Peel
Laser Skin Resurfacing
Photorejuvenation
Others
Hair Removal
Nonsurgical Fat Reduction
Sclerotherapy
Cellulite Treatment
By End Use :
Hospital/Surgery Center
MedSpa
Traditional Spa
HCP owned clinic
By Region :
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Get Customization on this Report for Specific Research Solutions
More Insights Available
Fact.MR, in its new offering, presents an unbiased analysis of the Non-Invasive aesthetic treatment market, presenting historical market data (2015-2021) and forecast statistics for the period of 2022-2032.
The study reveals essential insights based on Procedure (Injectables, Skin Rejuvenation and Other Procedures) and End User (Hospital/Surgery Center, MedSpa, Traditional Spa, and HCP Owned Clinic) across five regions (North America, Latin America, Europe, Asia Pacific and the Middle East & Africa).
About the Healthcare Division at Fact.MR
Expert analysis, actionable insights, and strategic recommendations of the highly seasoned Healthcare team at Fact.MR helps clients from across the globe with their unique business intelligence needs. With a repertoire of over a thousand reports and 1 million-plus data points, the team has analyzed the healthcare industry across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services.
Check out more studies related to Healthcare Industry, conducted by Fact.MR:
Lab Automation Market - Lab Automation Market by Product (Equipment, Microplate Readers, Software & Informatics, Automated ELISA Systems, Automated Nucleic Acid Purification Systems), by Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions) - Forecast to 2021-2031
Heart Attack Diagnostics Market - Heart Attack Diagnostics Market Analysis by Test (Electrocardiogram, Blood Tests, Angiogram, Computerized Cardiac Tomography, and Other Tests), by End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Other End Users), and by Region – Forecast to 2022-2032
Facial Implants Market - Facial Implants Market Analysis by Product (Chin and Mandibular, Cheek, Nasal, Injectables), by Material (Metal, Biologicals, Polymers, Ceramic), by Procedure (Eyelid Surgery, Facelift, Rhinoplasty) and by Region- 2022 to 2032
Smart Implants Market - Smart Implants Market Analysis, By Implant (Pacemakers, CRTs, ICDs, Knee Replacement, I-CGM, Cochlear Implants, Sacral Neuromodulators, DRG Neurostimulators, Spinal Cord Stimulators), By Use Case (Cardiac Rhythm Management, Arthroplasty, Neuromodulation, Continuous Glucose Monitoring Hearing), By End User (Hospitals, Specialty Clinics, ASCS) - Global Market Insights 2022 to 2032
Animal Model Market - Animal Model Market Analysis by Species (Rats, Mice, Guinea Pig, Rabbits, Monkeys, Dogs, Pigs, Cats, and Other Species), by Application (Basic & Applied Research and Drug Discovery/Development), by End User (Academic & Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), and Other End Users) and Region Forecast- 2022-2032
Nerve Monitoring Devices Market - Nerve Monitoring Devices Market Analysis by Product (Nerve monitors, Nerve Stimulation Electrode and Probes) by Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECOG), Evoked Potential (EP)) by Application (Neurosurgery, ENT surgery, Cardiovascular, others) by End Users (Hospitals, Ambulatory surgical centers ) and by Region- 2022 to 2032
Biotechnology Instruments Market - Biotechnology Instruments Market by Component (Lab Automation Instruments, Medical Lasers, Life Science Consumables) by End Use (Government & Academic Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Facilities, Other End Uses) & by Region- 2022-2032
Bioabsorbable Stents Market - Bioabsorbable Stents Market Analysis by Material (Bioabsorbable polymer based stents, and Bioabsosbable metallic stents), by Absorption Rate (Slow- absorption stents, and Fast- absorption stents), by Application (Coronary Artery Diseases, and Peripheral Artery Diseases), by End User (Hospitals, and Cardiac Centres), and by Region – Forecast to 2022-2032
Blood Flow Measurement Devices Market - Blood Flow Measurement Devices Market Analysis by Product (Ultrasound - Doppler Ultrasound, Transit time Flow Meters (TTFM), Laser Doppler), Application (Non-invasive - Cardiovascular Disease, Diabetes, Dermatology, Invasive - CABG, Microvascular Surgery), by Region - Global Forecast 2022-2032
Transcatheter Valve Replacement Market - Transcatheter Valve Replacement Market Analysis, By Replacement Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR)), By Surgical Approach (Trans-femoral Approach, Trans-apical Approach, Trans-aortic Approach), By End User (Hospitals, Ambulatory Surgical Centres, Specialty Clinics) - Global Market Insights 2022 to 2032
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.